📚 Lecture Overview
This lecture explores Idiopathic Inflammatory Myopathies (IIM), a group of rare heterogeneous muscle disorders characterized by chronic, progressive symmetrical proximal muscle weakness and unique extramuscular features. Mastering this material is essential for clinical practice, as early diagnosis and treatment can prevent permanent muscle damage, limit atrophy, and uncover hidden malignancies.
🎯 Key Concepts & Definitions
- Polymyositis (PM): An idiopathic inflammatory myopathy characterized by insidious, symmetric proximal muscle weakness without characteristic rashes.
- Dermatomyositis (DM): An inflammatory myopathy featuring characteristic cutaneous manifestations alongside proximal muscle weakness.
- Dermatomyositis Sine Myositis: A presentation of dermatomyositis involving skin disease without overt muscle involvement, carrying a risk of aggressive interstitial lung disease.
- Inclusion Body Myositis (IBM): A distinct form of myositis affecting older men, noted for focal, distal, or asymmetric weakness, borderline enzyme elevations, and poor response to therapy.
- Myositis-Specific Autoantibodies: Diagnostic immune markers like anti-Jo-1 and anti-Mi-2 that correlate with specific clinical phenotypes.
📖 Main Content
1. Classification of Skeletal Muscle Disorders
- Skeletal muscle disorders are broadly divided into non-inflammatory and inflammatory categories:
- Non-inflammatory: Hereditary (e.g., Duchenne), endocrinal (e.g., Cushing, hypothyroidism), metabolic, and electrolyte disturbances (e.g., hypokalemia).
- Inflammatory: Idiopathic inflammatory myopathies, infectious agents, malignancies, and drugs/toxins.
- Idiopathic Inflammatory Myopathies include:
- Polymyositis
- Dermatomyositis
- Inclusion body myositis
- Juvenile DM-PM
- Myositis with other connective tissue disorders (e.g., SLE, RA, scleroderma, sarcoidosis).
2. Clinical Picture of Polymyositis (PM)
- Proximal muscle weakness presents in 90-95% of patients, usually with an insidious onset.
- Limb girdle muscles:
- Shoulder girdle: Difficulty combing hair, lifting objects, and performing household duties.
- Pelvic girdle: Difficulty climbing stairs and rising from a sitting position.
- Neck flexors and pharyngeal muscles: Neck extension weakens first, leading to head drop; pharyngeal involvement causes dysphagia.
- Ocular muscles are never involved in idiopathic inflammatory myopathies.
- Cardiac and respiratory muscles can be impacted, leading to dilated cardiomyopathy and interstitial pneumonitis.
3. Cutaneous Features of Dermatomyositis (DM)
- Rash is the primary presenting feature in 95% of DM patients; only 50-60% have proximal muscle weakness at presentation.
- Key cutaneous signs to memorize:
- Heliotrope rash: Violaceous discoloration of eyelids with periorbital edema.
- Gottron sign papules: Symmetric scaly/erythematous eruptions over extensor surfaces of MCP/IP joints, elbows, and knees.
- Mechanic's hands: Dark or dirty-appearing horizontal lines over palmar and lateral aspects of fingers.
- Shawl sign: Macular erythema over posterior shoulders and chest.
- V sign: Macular erythema over anterior neck and upper chest.
- Holster sign: Rash on the lateral part of the thigh.
- Calcinosis: Cutaneous deposits of basic calcium phosphate in hands and periarticular tissue.
4. Diagnosis & Investigations
- Diagnostic criteria rely on five pillars: symmetric proximal weakness, elevated muscle enzymes (CK, aldolase, LDH, AST), typical EMG triad, chronic inflammation on muscle biopsy, and characteristic DM rashes.
- EMG Triad:
1. Increased insertional activity, fibrillations, and sharp positive waves.
2. Spontaneous, bizarre, high-frequency discharges.
3. Polyphasic motor-unit potentials of low amplitude and short duration. - Muscle Biopsy Differences:
- Dermatomyositis: B cells, macrophages, decreased capillaries, perifascicular atrophy, perivascular infiltrate.
- Polymyositis: Mononuclear cells, CD8 T cells, endomysial infiltrate, myonecrosis.
- IBM: Same as PM plus rimmed vacuoles and eosinophilic cytoplasmic inclusions.
5. Malignancy Association and Treatment
- Malignancy risk: Patients with PM-DM have a four times greater risk of malignancy; 10% to 20% have an underlying cancer (higher in DM). Myositis precedes malignancy by 1 to 2 years in 70% of cases.
- Treatment outline:
- First-line therapy: High-dose oral corticosteroids (40–60 mg/day prednisone).
- Immunosuppressive agents: Methotrexate (MTX) is the first-line steroid-sparing agent. Others include Mycophenolate mofetil, Azathioprine, Cyclophosphamide, and IVIG.
- Hydroxychloroquine helps ameliorate skin manifestations.
📊 Visual Learning
flowchart TD
A[Initial Presentation] --> B{Cutaneous Rash Present?}
B -->|Yes 95 pct| C[Check For Dermatomyositis]
B -->|No| D[Check For Polymyositis]
C --> E[Evaluate Gottron Sign and Heliotrope]
D --> F[Assess Proximal Weakness]
E --> G[Screen For Malignancy]
F --> G
mindmap
root("Inflammatory Myopathies")
"Polymyositis"
"Proximal Weakness"
"CD8 T Cells"
"No Ocular Involvement"
"Dermatomyositis"
"Heliotrope Rash"
"Gottron Papules"
"Perifascicular Atrophy"
"Malignancy Risk"
"Inclusion Body Myositis"
"Older Men"
"Rimmed Vacuoles"
"Resistant to Therapy"
graph LR
A[Patient Symptoms] --> B[Elevated CK Enzymes]
A --> C[EMG Findings]
A --> D[Muscle Biopsy]
B --> E[Definitive Diagnosis]
C --> E
D --> E
E --> F[Corticosteroids]
E --> G[Methotrexate]
💡 Important Points to Remember
- Ocular sparing: Ocular muscles are never involved in polymyositis or dermatomyositis.
- Enzyme elevations: Creatine Kinase (CK) is often elevated to greater than 10 times normal.
- Biopsy hallmarks: Polymyositis features endomysial CD8 T cells, while Dermatomyositis features perifascicular atrophy and perivascular B cell infiltration.
- IBM exception: Inclusion Body Myositis affects older men, causes distal/asymmetric weakness, shows borderline enzyme levels, and responds poorly to therapy.
- Malignancy window: Myositis can precede underlying solid organ tumors by 1 to 2 years.
- First-line steroid-sparing: Methotrexate is the preferred choice after corticosteroids fail or for steroid-refractory cases.
- Skin without muscle: Dermatomyositis sine myositis presents with skin lesions and severe interstitial lung disease without overt muscle weakness.
- EMG limitations: 10-15% of patients with clinically proven inflammatory myopathy have completely normal EMGs.
⚠️ Common Exam Questions
- Classic MCQ Trick: Examiners will ask about a patient presenting with progressive muscle weakness and diplopia or ptosis. Students often choose Polymyositis, but ocular muscle involvement excludes IIM (think Myasthenia Gravis instead).
- Biopsy Confusion: Questions frequently test the difference between PM and DM biopsies. Remember: DM = Perifascicular atrophy; PM = Endomysial CD8 infiltration; IBM = Rimmed vacuoles.
- Malignancy Association: Expect a vignette regarding an elderly patient with a violet periorbital rash and proximal weakness; the key association to identify is an increased risk of underlying malignancy.
📝 Quick Review Checklist
I can explain pathogenic mechanisms in inflammatory myopathies
I understand the differences between polymyositis and dermatomyositis clinical pictures
I can define the characteristic cutaneous signs of dermatomyositis (Gottron papules, heliotrope rash)
I know how to interpret diagnostic muscle biopsy findings for PM, DM, and IBM
I understand the association between dermatomyositis and underlying malignancy
I know the primary treatment protocol including corticosteroids and methotrexate